As we have seen with certain vaccines over the last 18 months, cryogenic transport and storage is becoming a significant issue for biopharmaceutical manufacturers as more products and components must be stored at very low temperatures to be kept functional. The repercussions of these new requirements are being felt throughout the biopharmaceutical production industry as…